Your browser doesn't support javascript.
loading
Mammographic Screening in the Occupied Palestinian Territory: A Critical Analysis of Its Promotion, Claimed Benefits, and Safety in Palestinian Health Research.
AlWaheidi, Shaymaa; McPherson, Klim; Chalmers, Iain; Sullivan, Richard; Davies, Elizabeth A.
Afiliação
  • AlWaheidi S; Cancer Epidemiology, Population and Global Health, King's College London, London, United Kingdom.
  • McPherson K; Public Health Epidemiology, Nuffield Department of Primary Health Care Research and New College, University of Oxford, Oxford, United Kingdom.
  • Chalmers I; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
  • Sullivan R; Institute of Cancer Policy, Kings Health Partners Comprehensive Cancer Centre, King's College London, London, United Kingdom.
  • Davies EA; Cancer Epidemiology, Population and Global Health, King's College London, London, United Kingdom.
JCO Glob Oncol ; 6: 1772-1790, 2020 11.
Article em En | MEDLINE | ID: mdl-33206549
ABSTRACT

PURPOSE:

To critically review the evidence and opinions expressed about mammographic screening (MS) in research reports on breast cancer in the occupied Palestinian territory (oPt) and to assess whether benefits and harms in MS are presented in a balanced way.

METHODS:

Searches of PubMed, Cochrane, MEDLINE, EMBASE, CINAHL, and gray literature identified 14 eligible research reports relating to the oPt. We reviewed these documents and then used a thematic analysis to describe and analyze the evidence and the opinions about MS expressed in them.

RESULTS:

All 14 research reports mentioned that MS would improve survival rates in the oPt. Only three gave information on major harmful effects, and only two emphasized that MS must be accompanied by effective treatment to have any beneficial effects on population mortality. There was no consistency in the recommended frequency of MS.

CONCLUSION:

Most information presented by Palestinian health researchers was selective and failed to address the important established harms of MS. Thus, calls to support MS in the oPt are not based on a measured discussion of the risks and benefits for women or grounded in the systemic readiness of health care necessary for its effectiveness. As long as diagnostic and treatment facilities remain deficient, screening cannot lead to reduced mortality from breast cancer.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Árabes Tipo de estudo: Diagnostic_studies / Screening_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Árabes Tipo de estudo: Diagnostic_studies / Screening_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article